Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidogrel vs Plavix in Coronary Disease (CAPP)
NCT01431495Phase 4Completed
- Sponsor
- Les Laboratoires des Médicaments Stériles
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel in coronary artery disease (CAD) (2 arms), sponsored by Les Laboratoires des Médicaments Stériles. Primary endpoints: Platelet reactivity by VerifyNow assay and Major Adverse Cardiovascular Events at 6 months. Started Apr 2010; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01431495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431495.